Sara L. G.
- Country
- Italy
- Department
- #2335: Centro Sclerosi Multipla U.S.S. Neuroimmunologia
Research Overview
- Efficacy and Safety of Remibrutinib in Patients with Secondary Progressive Multiple Sclerosis: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study
- Evaluation of Human Fetal Neural Precursor Cells and Tacrolimus in Progressive Multiple Sclerosis: A Randomized, Assessor-Blind, Multicenter Phase 2 Study
- Non-Inferiority Study of Remibrutinib Versus Ocrelizumab in Relapsing Multiple Sclerosis Patients Transitioning to Remibrutinib Therapy
Data & Insights
Has run more than one trial at 38 of 194 partner sites.
Specializations
Neurological Disorders
This investigator specializes in the treatment of Progressive Multiple Sclerosis, exploring innovative therapeutic approaches in neurodegenerative conditions.
- Multiple Sclerosis Management
- Neurodegenerative Disorders
- Progressive Neurological Conditions
The research focuses on advanced therapeutic interventions for progressive neurological disorders.
Regenerative Medicine
The investigator's work centers on neural stem cell therapy, particularly exploring cellular transplantation techniques for neurological conditions.
- Stem Cell Applications
- Cell-Based Therapies
- Neural Regeneration
Primary interest lies in developing cellular therapeutic approaches for neurological disorders.
Treatment Innovation
Research activities involve intrathecal administration techniques and novel therapeutic delivery methods for neurological conditions.
- Advanced Treatment Methods
- Therapeutic Administration
- Clinical Applications
The focus includes developing innovative treatment delivery approaches for neurological diseases.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.